SCHEMBL5376699

SCHEMBL5376699

COc1ccc(Br)c(C=C2C(=O)Nc3ccc(CCCl)cc32)c1O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLK4 O00444 3/20 0.49
PLK1 P53350 2/20 0.49
LRRK2 Q5S007 2/20 0.48
RAF1 P04049 5/20 0.44
AURKA O14965 1/20 0.44
PSEN1 P49768 2/20 0.43
PSEN2 P49810 2/20 0.43
APH1B Q8WW43 2/20 0.43
NCSTN Q92542 2/20 0.43
APH1A Q96BI3 2/20 0.43
PSENEN Q9NZ42 2/20 0.43
DHFR P00374 1/20 0.43
MDM2 Q00987 2/20 0.43
CSNK1D P48730 3/20 0.42
CSNK1A1 P48729 2/20 0.42
CSNK1E P49674 2/20 0.42
GMNN O75496 2/20 0.42
LMNA P02545 2/20 0.42
TP53 P04637 2/20 0.42
CYP1A2 P05177 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5369940 0.84 CSNK1D (0.46) PLK4PLK1LRRK2PSEN1PSEN2
SCHEMBL5366431 0.83 RAF1 (0.61) PLK4PLK1LRRK2RAF1AURKA
SCHEMBL5361740 0.82 PLK4 (0.54) PLK4PLK1LRRK2RAF1AURKA
SCHEMBL5359526 0.82 NPC1 (0.51) PLK4PLK1LRRK2PSEN1PSEN2
SCHEMBL5376881 0.82 CSNK1D (0.46) PLK4PLK1LRRK2PSEN1PSEN2
SCHEMBL5357633 0.81 CSNK1D (0.64) PLK4LRRK2AURKAPSEN1PSEN2
SCHEMBL5367287 0.81 LRRK2 (0.57) PLK4PLK1LRRK2RAF1AURKA
SCHEMBL7133855 0.81 ERBB2 (0.53) PLK4PLK1LRRK2PSEN1PSEN2
SCHEMBL5364261 0.79 MDM2 (0.55) PLK4PLK1PSEN1PSEN2APH1B
SCHEMBL5358042 0.78 NTRK1 (0.51) PLK4PLK1LRRK2RAF1AURKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7202265-B2 Indolinone combinatorial libraries and related products and methods for the treatment of disease SUGEN, INC. (US) 2007-04-10 US disclosed
US-20050197382-A1 Indolinone combinatorial libraries and related products and methods for the treatment of disease SUGEN, INC. 2005-09-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050197382-A1 Indolinone combinatorial libraries and related products and methods for the treatment of disease FRK, PTK2, DSTYK PLK4 42/4885PLK1 201/4885LRRK2 289/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.